OpenAlex records 37 works, 926 citations, and an h-index of 15, with sustained productivity 2016β2023 and a citation peak in 2023 (~219 that year) . Note the Semantic Scholar-style snippet (h-index 1, 2 papers) is a fragmentary entity split and should not be used to judge her.
Her domain is CoQ biosynthesis and mitochondrial metabolism. Key contributions: a widely cited 2018 review on CoQ deficiencies (137 citations) ; first-author work showing kaempferol as a CoQ ring precursor ; and middle-author contributions to high-profile studies on NAFLD lysosomal rescue in Nature Communications and ATP synthase reverse-activity inhibition in EMBO Journal .
Strengths: consistent specialization (CoQ/mitochondria), publication in top-tier journals (JCI, Nature Communications, EMBO J, JASN), strong methodological breadth (metabolomics, respirometry, RNA-seq, mouse genetics β e.g., JCI 2026 Abcc6 work with n=6/group tissue-specific knockouts, deposited GEO datasets ). Limitations: she is mostly a middle author on her most-cited papers; first-author leadership is concentrated in reviews and early-career work; citation trajectory dipped in 2024β2026 (few citations on recent papers), though knowledge half-life for 2023β2026 work is short. Blind spots: no verified independent PI status or funding record visible; entity fragmentation inflates uncertainty in metrics.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.